Blogroll

Uber Technologies Inc said on Wednesday trip requests were gradually picking up, but still remained significantly below prior year levels, as several countries start to lift coronavirus-led restrictions.

A study by the Netherlands' National Institute for Health (RIVM) published on Wednesday concluded that children under the age of 12 play little role in transmitting the new coronavirus.

The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

U.S. President Donald Trump had no side effects from a two-week course of hydroxychloroquine, an anti-malaria drug that can cause heart problems, after using it as a preventive measure against the coronavirus, his White House physician said on Wednesday.

The Dutch government on Wednesday ordered mink culled at nine farms where animals have been infected with the coronavirus, fearing they could form a reservoir of disease infecting humans after the country's current outbreak has passed.

The malaria drug promoted by U.S. President Donald Trump as a treatment for COVID-19 was shown to be ineffective in preventing infection in people exposed to the coronavirus, according to a widely anticipated clinical trial released on Wednesday.

The Spanish government on Wednesday secured parliament's backing for a final extension to the state of emergency imposed to tackle the coronavirus epidemic and which will now last until June 21.

ZoomInfo Technologies Inc is looking to price its initial public offering (IPO) on Wednesday above its upwardly revised target range in what is set to be the largest U.S. technology listing so far this year, people familiar with the matter said

France's coronavirus death toll rose by 81 on Wednesday, or 0.3%, to reach 29,021, the fifth-highest death toll in the world, and the number of confirmed cases rose again after they went down Tuesday due to an adjustment in reporting.

The World Health Organization will resume its trial of hydroxychloroquine for potential use against the coronavirus, its chief said on Wednesday, after those running the study briefly stopped giving it to new patients over health concerns.

Germany will outlaw the 'morphing' of passport photos, in which pictures of two people are digitally combined, making it possible to assign multiple identities to a single document.

A federal judge said Apple Inc must face part of a lawsuit claiming it fraudulently concealed falling demand for iPhones, especially in China, leading to tens of billions of dollars in shareholder losses.

Brazil's health regulator Anvisa has approved human clinical trials for a potential coronavirus vaccine developed by scientists at Oxford University and supported by AstraZeneca Plc, it said on Wednesday.

The U.S. Centers for Disease Control and Prevention (CDC) on Wednesday reported 1,827,425 cases of new coronavirus, an increase of 24,955 cases from its previous count, and said the number of deaths had risen by 1,045 to 106,202.

Mexico's death toll from the coronavirus pandemic may reach 30,000, a senior health official said in a newspaper interview published on Wednesday, while suggesting fatalities could be even higher if social distancing measures were relaxed too fast.

Emergency department visits fell 42% across the United States during the early days of the coronavirus pandemic compared to the same period last year, according to a study by the U.S. Centers for Disease Control and Prevention (CDC).

The amorphous internet activist movement known as Anonymous staged an online resurgence in the past week on the back of real-world protests against police brutality.

Gilead Sciences Inc's potential COVID-19 treatment, remdesivir, could bring in more than $7 billion in annual sales by 2022, spurred by governments stockpiling the drug to guard against future outbreaks, SVB Leerink said on Wednesday.

The GAVI vaccines alliance is to launch an Advance Market Commitment (AMC) for future COVID-19 vaccines which it says will help secure access to the new shots for poorer countries.

Sanofi said on Wednesday it would review available information and run consultations before deciding whether to enroll patients again for its COVID-19-related hydroxychloroquine trials.